Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin.

Matsuda R, Anguizola J, Joseph KS, Hage DS.

Anal Bioanal Chem. 2011 Nov;401(9):2811-9. doi: 10.1007/s00216-011-5382-8. Epub 2011 Sep 16.

2.

Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.

Matsuda R, Jobe D, Beyersdorf J, Hage DS.

J Chromatogr A. 2015 Oct 16;1416:112-20. doi: 10.1016/j.chroma.2015.09.023. Epub 2015 Sep 9.

3.

Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography.

Matsuda R, Li Z, Zheng X, Hage DS.

Anal Bioanal Chem. 2015 Jul;407(18):5309-21. doi: 10.1007/s00216-015-8688-0. Epub 2015 Apr 26.

PMID:
25912461
4.

Binding of tolbutamide to glycated human serum albumin.

Joseph KS, Anguizola J, Hage DS.

J Pharm Biomed Anal. 2011 Jan 25;54(2):426-32. doi: 10.1016/j.jpba.2010.09.003. Epub 2010 Sep 15.

5.

Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Matsuda R, Anguizola J, Joseph KS, Hage DS.

J Chromatogr A. 2012 Nov 23;1265:114-22. doi: 10.1016/j.chroma.2012.09.091. Epub 2012 Oct 8.

6.

Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.

Matsuda R, Li Z, Zheng X, Hage DS.

J Chromatogr A. 2015 Aug 21;1408:133-44. doi: 10.1016/j.chroma.2015.07.012. Epub 2015 Jul 6. Erratum in: J Chromatogr A. 2015 Dec 4;1423:190.

7.

Chromatographic analysis of acetohexamide binding to glycated human serum albumin.

Joseph KS, Anguizola J, Jackson AJ, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2775-81. doi: 10.1016/j.jchromb.2010.08.021. Epub 2010 Aug 21.

8.

Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.

Joseph KS, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 1;878(19):1590-8. doi: 10.1016/j.jchromb.2010.04.019.

9.

Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.

Anguizola J, Debolt E, Suresh D, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 May 15;1021:175-81. doi: 10.1016/j.jchromb.2015.09.041. Epub 2015 Oct 9.

10.

Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.

Basiaga SB, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3193-7. doi: 10.1016/j.jchromb.2010.09.033. Epub 2010 Oct 23.

11.

The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Joseph KS, Hage DS.

J Pharm Biomed Anal. 2010 Nov 2;53(3):811-8. doi: 10.1016/j.jpba.2010.04.035. Epub 2010 May 6.

12.

Analysis of drug-protein interactions by high-performance affinity chromatography: interactions of sulfonylurea drugs with normal and glycated human serum albumin.

Matsuda R, Anguizola J, Hoy KS, Hage DS.

Methods Mol Biol. 2015;1286:255-77. doi: 10.1007/978-1-4939-2447-9_21.

PMID:
25749961
13.

Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography.

Soman S, Yoo MJ, Jang YJ, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 1;878(7-8):705-8. doi: 10.1016/j.jchromb.2010.01.016. Epub 2010 Jan 25.

14.

Effects of glycosylation of hypoglycaemic drug binding to serum albumin.

Koyama H, Sugioka N, Uno A, Mori S, Nakajima K.

Biopharm Drug Dispos. 1997 Dec;18(9):791-801.

PMID:
9429743
15.

Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.

Joseph KS, Moser AC, Basiaga SB, Schiel JE, Hage DS.

J Chromatogr A. 2009 Apr 17;1216(16):3492-500. doi: 10.1016/j.chroma.2008.09.080. Epub 2008 Oct 1.

16.

Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.

Jackson AJ, Anguizola J, Pfaunmiller EL, Hage DS.

Anal Bioanal Chem. 2013 Jul;405(17):5833-41. doi: 10.1007/s00216-013-6981-3. Epub 2013 May 9.

17.

Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.

Mallik R, Yoo MJ, Chen S, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 1;876(1):69-75. doi: 10.1016/j.jchromb.2008.10.022. Epub 2008 Oct 21.

18.

Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin.

Seedher N, Kanojia M.

Chem Biol Drug Des. 2008 Oct;72(4):290-6. doi: 10.1111/j.1747-0285.2008.00704.x.

PMID:
18844675
19.

Studies of imipramine binding to human serum albumin by high-performance affinity chromatography.

Yoo MJ, Smith QR, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1149-54. doi: 10.1016/j.jchromb.2009.02.070. Epub 2009 Mar 10.

20.

Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.

Zheng X, Matsuda R, Hage DS.

J Chromatogr A. 2014 Dec 5;1371:82-9. doi: 10.1016/j.chroma.2014.10.092. Epub 2014 Oct 31.

Supplemental Content

Support Center